share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP:信函
美股SEC公告 ·  08/23 13:08
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corporation has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated August 23, 2024. The company, headquartered in Denver, Colorado, seeks to have the Registration Statement become effective at 4:30 p.m. Eastern Time on August 27, 2024, or as soon as possible thereafter. SeaStar Medical's CEO, Eric Schlorff, signed the request, indicating the company's readiness to proceed with the registration process. The SEC has been asked to confirm the effectiveness of the Registration Statement orally with SeaStar Medical's counsel, Dorsey & Whitney LLP, following its declaration.
SeaStar Medical Holding Corporation has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated August 23, 2024. The company, headquartered in Denver, Colorado, seeks to have the Registration Statement become effective at 4:30 p.m. Eastern Time on August 27, 2024, or as soon as possible thereafter. SeaStar Medical's CEO, Eric Schlorff, signed the request, indicating the company's readiness to proceed with the registration process. The SEC has been asked to confirm the effectiveness of the Registration Statement orally with SeaStar Medical's counsel, Dorsey & Whitney LLP, following its declaration.
SeaStar医疗控股公司正式要求美国证券交易委员会(SEC)加快其S-3表格的注册声明生效日期,日期为2024年8月23日的信函。总部位于科罗拉多州丹佛市的公司希望该注册声明在2024年8月27日东部时间下午4:30生效,或尽快生效。 SeaStar医疗的首席执行官Eric Schlorff签署了请求,表示公司已准备好继续进行注册流程。已要求SEC在声明后与SeaStar医疗的顾问律所Dorsey & Whitney LLP口头确认注册声明的有效性。
SeaStar医疗控股公司正式要求美国证券交易委员会(SEC)加快其S-3表格的注册声明生效日期,日期为2024年8月23日的信函。总部位于科罗拉多州丹佛市的公司希望该注册声明在2024年8月27日东部时间下午4:30生效,或尽快生效。 SeaStar医疗的首席执行官Eric Schlorff签署了请求,表示公司已准备好继续进行注册流程。已要求SEC在声明后与SeaStar医疗的顾问律所Dorsey & Whitney LLP口头确认注册声明的有效性。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息